Mimedx (MDXG) Net Margin (2016 - 2025)
Historic Net Margin for Mimedx (MDXG) over the last 15 years, with Q4 2024 value amounting to 8.01%.
- Mimedx's Net Margin fell 436200.0% to 8.01% in Q4 2024 from the same period last year, while for Sep 2025 it was 1.89%, marking a year-over-year decrease of 212700.0%. This contributed to the annual value of 12.04% for FY2024, which is 53200.0% down from last year.
- As of Q4 2024, Mimedx's Net Margin stood at 8.01%, which was down 436200.0% from 9.37% recorded in Q3 2024.
- In the past 5 years, Mimedx's Net Margin registered a high of 51.63% during Q4 2023, and its lowest value of 80.84% during Q3 2020.
- In the last 5 years, Mimedx's Net Margin had a median value of 4.93% in 2021 and averaged 4.57%.
- In the last 5 years, Mimedx's Net Margin plummeted by -947700bps in 2020 and then soared by 746400bps in 2021.
- Quarter analysis of 5 years shows Mimedx's Net Margin stood at 26.35% in 2020, then skyrocketed by 90bps to 2.75% in 2021, then soared by 498bps to 10.94% in 2022, then surged by 372bps to 51.63% in 2023, then crashed by -84bps to 8.01% in 2024.
- Its Net Margin was 8.01% in Q4 2024, compared to 9.37% in Q3 2024 and 20.21% in Q2 2024.